Peptide Therapeutics Market PPT 2022: Size, Growth, Demand and Forecast till 2027

1
Global Peptide Therapeutics Market Research and
Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Peptide Therapeutics Market Research
Report 2022-2027 According to the latest report
by IMARC Group, titled "Peptide Therapeutics
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast
2022-2027," the global peptide therapeutics
market reached a value of US 35.9 Billion in
2021. Peptides refer to naturally occurring,
short chains of amino acid monomers that are
connected with cell surface receptors for
triggering intracellular effects. They are
extremely small, versatile, and offer higher
efficacy than other clinical practices
therefore, they are extensively used for
engineering novel regenerative medications as
they can target varying cells and manipulate
their reactions. Along with this, peptide
therapeutics are non-toxic, well-tolerated, and
offer anti-inflammatory properties, which help in
improving the immune system, repairing muscle
tendons, and acting as an antioxidant for
treating several metabolic disorders.
Consequently, they are being employed for
managing cancer, injuries, aesthetic concerns,
and multiple infectious diseases. Request for a
PDF sample of this report https//www.imarcgroup.
com/peptide-therapeutics-market/requestsample

4
Report Description and Highlights
Report Description
Global Peptide Therapeutics Market Trends With
the increasing prevalence of various chronic and
metabolic disorders, especially amongst the
geriatric population, there has been a rising
need for effective medications, which in turn,
has facilitated the widespread adoption of
peptide therapeutics across the healthcare sector
for treatment purposes. Additionally, the rising
consciousness amongst consumers regarding their
physical appearance has supplemented the
utilization of peptide therapeutics in
cosmeceutical surgeries as they slow down the
aging process, which is acting as another
growth-inducing factor. In line with this,
extensive investments being made by governments
of several countries in pharmaceutical companies
to develop innovative novel peptide medications
and synthetic strategies to improve product
stability are contributing to the market growth.
Moreover, escalating awareness amongst
individuals regarding the availability of
personalized medicines and the ongoing clinical
trials by healthcare professionals to develop and
execute precise non-invasive treatment procedures
to treat autoimmune and inflammatory diseases are
impelling the market growth. Other factors, such
as the significant expansion in the healthcare
infrastructure and continuous research and
development (RD) activities to engineer
multi-purpose peptide-based materials, are
creating a positive outlook for the market.

5
Report Description and Highlights
Report Description
Looking forward, IMARC Group expects the market
to reach a value of US 61.9 Billion by 2027,
exhibiting at a CAGR of 9.42 during
2022-2027. View Report TOC, Figures and Tables
https//www.imarcgroup.com/peptide-therapeutics-ma
rket

6
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Type
• Innovative
• Generic
•  
• Breakup by Type of Manufacturer
• Outsourced
• In-house
• Breakup by Synthesis Technology
• Solid Phase Peptide Synthesis
• Liquid Phase Peptide Synthesis
• Hybrid Technology
• Breakup by Routes of Administration
• Parenteral
• Oral
• Others

7
Report Description and Highlights
Report Description

•  
• Breakup by Application
• Gastrointestinal Disorders
• Neurological Disorders
• Metabolic Disorders
• Cancer
• Others
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
•  

8
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Amgen Inc
• Apitope International NV
• Arch Biopartners Inc
• AstraZeneca plc
• Circle Pharma Inc
• Corden Pharma GmbH
• F. Hoffmann-La Roche AG
• Ipsen Group
• Lonza Group AG
• Novo Nordisk A/S
• Pfizer Inc
• Teva Pharmaceuticals Industries Ltd
• Zealand Pharma A/S
•  

9
Key Questions Answered in the Report
Report Description

• How has the global peptide therapeutics market
  performed so far and how will it perform in the
  coming years?
• What has been the impact of COVID-19 on the
  global peptide therapeutics market?
• What are the key regional markets?
• What is the breakup of the market based on the
  type?
• What is the breakup of the market based on the
  type of manufacturer?
• What is the breakup of the market based on the
  synthesis technology?
• What is the breakup of the market based on the
  routes of administration?
• What is the breakup of the market based on the
  application?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global peptide
  therapeutics market and who are the key players?
• What is the degree of competition in the
  industry?
•  

10
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Peptide Therapeutics
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

11
Table of Contents
Report Description
6    Market Breakup by Type    6.1  
 Innovative        6.1.1 Market Trends       
6.1.2 Market Forecast    6.2    Generic       
6.2.1 Market Trends        6.2.2 Market
Forecast7    Market Breakup by Type of
Manufacturer    7.1    Outsourced        7.1.1
Market Trends        7.1.2 Market Forecast   
7.1    In-house        7.1.1 Market Trends     
  7.1.2 Market Forecast        8    Market
Breakup by Synthesis Technology    8.1     Solid
Phase Peptide Synthesis        8.1.1 Market
Trends        8.1.2 Market Forecast Click here
to visit the complete table of content with list
of figures and tables https//www.imarcgroup.com/
peptide-therapeutics-market/toc

12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
14
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
15

Contact Us